Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test

European Neuropsychopharmacology

Volumn 18, Issue 5, 2008, Pages 323-332

  Ghasemi, Mehdi ^a   Sadeghipour, Hamed ^a   Mosleh, Afsaneh ^a   Sadeghipour, Hamid Reza ^a   Mani, Ali Reza ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Depression; Forced swimming test; l arginine; Lithium; Nitric oxide (NO); Nitric oxide synthase (NOS) inhibitor

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ANTIDEPRESSANT AGENT; ARGININE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; LITHIUM; N(G) NITROARGININE METHYL ESTER; N(G) PROPYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FREEZING REACTION, CATALEPTIC; LITHIUM COMPOUNDS; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; SWIMMING;

EID: 40749102904     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.07.011     Document Type: Article

References (70)

1. Anai H., Ueta Y., Serino R., Nomura M., Nakashima Y., and Yamashita H. Activation of hypothalamic neuronal nitric oxide synthase in lithium-induced diabetes insipidus rats. Psychoneuroendocrinology 26 (2001) 1009-1020
2. Bagetta G., Corasaniti M.T., Melino G., Paoletti A.M., Finazzi-Agro A., and Nistico G. Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem. Biophys. Res. Commun. 197 (1993) 1132-1139
3. Bai F., Li X., Clay M., Lindstrom T., and Skolnick P. Intra- and interstrain differences in models of "behavioural despair". Pharmacol. Biochem. Behav. 70 (2001) 187-192
4. Baron M., Gershon E.S., Rudy V., Jonas W.Z., and Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar-bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch. Gen. Psychiatry 32 (1975) 1107-1111
5. Bauer M., and Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J. Clin. Psychopharmacol. 19 (1999) 427-434
6. Berridge M.J., and Irvine R.F. Inositol phosphates and cell signalling. Nature 341 (1989) 197-205
7. Boerelin H.L., Gitlin M.J., Zoellner L.A., and Hammen C.I. Bipolar depression and antidepressant-induced mania: a naturalistic study. J. Clin. Psychiatry 59 (1998) 374-379
8. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19 (1995) 377-395
9. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-161
10. Bourin, M., Prica, C., in press. The role of mood stabilizers in the treatment of the depressive facet of bipolar disorders. Neurosci. Biobehav. Rev. [Electronic publication ahead of print].
11. Cade J.F.J. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 2 (1949) 349-352
12. Coryell W., Endicott J., and Keller M. Rapidly cycling affective disorder: demographics, diagnosis, family history, and course. Arch. Gen. Psychiatry 49 (1992) 126-131
13. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23 (2002) 238-245
14. Dehpour A.R., Aghadadashi H., Ghafourifar P., Roushanzamir F., Ghahremani M.H., Meysamee F., Rassaee N., and Koucharian A. Effect of chronic lithium administration on endothelium-dependent relaxation in rat aorta. Clin. Exp. Pharmacol. Physiol. 27 (2000) 55-59
15. Dehpour A.R., Sadr S.S., Nouroddini M., Shadan F., Nourozi A., Farahani M., and Sahebgharani M. Comparison of simultaneous administration of lithium with l-NAME or l-arginine on morphine withdrawal syndrome in mice. Hum. Psychopharmacol. Clin. Exp. 15 (2000) 87-93
16. Drummond A.H. Lithium and inositol lipid-linked signaling mechanisms. Trends Pharmacol. Sci. 8 (1987) 129-133
17. Esplugues J.V. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 135 (2002) 1079-1095
18. Feinstein D.L. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J. Neurochem. 71 (1998) 883-886
19. Freeman M.P., and Freeman S.A. Lithium: clinical considerations in internal medicine. Am. J. Med. 119 (2006) 478-481
20. Goodwin F.K., and Jamison K.R. Manic-Depressive Illness (1990), Oxford University Press, New York
21. Greil W., and Kleindienst N. Lithium in the long-term treatment of bipolar disorders. Eur. Arch. Psychiatry Clin. Neurosci. 253 (2003) 120-125
22. Harkin A., Bruce K.H., Craft B., and Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372 (1999) 207-213
23. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 14 (2004) 274-281
24. Harvey B.E. Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness?. Hum. Psychopharmacol. 11 (1996) 309-319
25. Harvey B.H., Carstens M.E., and Taljaard J.J. Evidence that lithium induces a glutamatergic: nitric oxide-mediated response in rat brain. Neurochem. Res. 19 (1994) 69-474
26. Hascoet M., Bourin M., and Khimake S. Additive effect of lithium and clonidine with 5-HT1A agonists in the forced swimming test. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18 (1994) 381-396
27. Hashioka S., Klegeris A., Monji A., Kato T., Sawada M., McGeer P.L., and Kanba S. Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 206 (2007) 33-42
28. Hata T., Itoh E., and Nishikawa H. Behavioural characteristics of SART stressed mice in the forced swim test and drug action. Pharmacol. Biochem. Behav. 51 (1995) 849-853
29. Heninger G.R., Charney D.S., and Sternberg D.E. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch. Gen. Psychiatry 40 (1983) 1335-1342
30. Honar H., Riazi K., Homayoun H., Demehri S., Dehghani M., Vafaie K., Ebrahimkhani M.R., Rashidi N., Gaskari S.A., and Dehpour A.R. Lithium inhibits the modulatory effects of morphine on susceptibility to pentylentetrazole-induced clonic seizure in mice: involvement of a nitric oxide pathway. Brain Res. 1029 (2004) 48-55
31. Inan S.Y., Yalcin I., and Aksu F. Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide mediated serotonin release and potassium channel modulation. Pharmacol. Biochem. Behav. 77 (2004) 457-464
32. Jefferys D., and Funder J. Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur. J. Pharmacol. 295 (1996) 131-135
33. Johnson G. Antidepressant effect of lithium. Compr. Psychiatry 15 (1974) 43-47
34. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 (2003) 441-443
35. Jope R.S., and Williams M.B. Lithium and brain signal transduction systems. Biochem. Pharmacol. 47 (1994) 429-441
36. Katona C.L. Lithium augmentation in refractory depression. Psychiatr. Dev. 6 (1988) 153-171
37. Kaster M.P., Ferreira P.K., Santos A.R.S., and Rodrigues A.L.S. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res. 165 (2005) 204-209
38. Khan M.C., Wickham E.A., and Reed J.V. Lithium versus placebo in acute depression: a clinical trial. Int. Clin. Psychopharmacol. 2 (1987) 47-54
39. Kitamura Y., Araki H., and Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol. Biochem. Behav. 71 (2002) 63-69
40. Kleindienst N., and Greil W. Lithium in the long-term treatment of bipolar disorders. Eur. Arch. Psychiatry Clin. Neurosci. 253 (2003) 120-125
41. Linder J., Fyro B., Pettersson U., and Werner S. Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A doubleblind study on the antidepressant effect of lithium and clomipramine. Acta Psychiatr. Scand. 80 (1989) 27-36
42. Lopez-Rubalcava C., and Lucki I. Strain differences in the behavioural effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacol. 22 (2000) 191-199
43. Lucki I., Dalvi A., and Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155 (2001) 315-322
44. Maruta S., Suzuki E., Yokoyama M., Sato T., Inada K., Watanabe S., and Miyaoka H. Effects of intraperitoneally injected lithium, imipramine and diazepam on nitrate levels in rat amygdale. Psychiatry Clin. Neurosci. 59 (2005) 358-361
45. Mendels J., Secunda S.K., and Dyson W.L. A controlled study of the antidepressant effect of lithium carbonate. Arch. Gen. Psychiatry 26 (1972) 154-157
46. Nahorski S.R., Ragan C.I., and Challiss R.A. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci. 12 (1991) 297-303
47. Nixon M.K., Hascoet M., Bourin M., and Colombel M.C. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) 115 (1994) 59-64
48. O'Brien W.T., Harper A.D., Jové F., Woodget J.R., Maretto S., and Piccolo S. Glycogen synthase kinase-3β haploinsufficiency mimics the behavioural and molecular effects of lithium. J. Neurosci. (2004) 6791-6798
49. Paoletti A.M., Piccirilli S., Costa N., Rotiroti D., Bagetta G., and Nistico G. Systemic administration of N omega-nitro-l-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat. Exp. Neurol. 149 (1998) 349-355
50. Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry 164 (1994) 549-550
51. Porsolt R.D., Bertin A., and Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
52. Price L.H., and Heninger G.R. Lithium in the treatment of mood disorders. N. Engl. J. Med. 331 (1994) 591-598
53. Redrobe J.P., and Bourin M. The effect of lithium administration in animal models of depression: a short review. Fundam. Clin. Pharmacol. 13 (1999) 293-299
54. Redrobe J.P., and Bourin M. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology 141 (1999) 370-377
55. Sadeghipour H., Ghasemi M., Nobakht M., Ebrahimi F., and Dehpour A.R. Effect of chronic lithium administration on endothelium-dependent relaxation of rat corpus cavernosum: the role of nitric oxide and cyclooxygenase pathways. BJU Int. 99 (2006) 177-182
56. Sadeghipour H., Ghasemi M., Ebrahimi F., and Dehpour A.R. Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway. Nitric Oxide 16 (2007) 54-63
57. Shaldubina A., Agam G., and Belmaker R.H. The mechanism of lithium action: state of the art, ten years later. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 (2001) 855-866
58. Sherman A.D., and Petty F. Neurochemical basis of the action of antidepressants on learned helplessness. Behav. Neural Biol. 30 (1980) 119-134
59. Shintani F., Kana S., Nakai T., Nakamura R., Sato K., Yagi G., Richelson E., Kato R., and Asai M. Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cells (N1E-115). Neuropsychopharmacol. 11 (1994) 119-124
60. Soares J.C., and Gershon A. The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacol. 19 (1998) 167-182
61. Solomon D.A., Keitner G.I., Miller I.W., Shea M.T., and Keller M.B. Course of illness and maintenance treatments for patients with bipolar disorder. J. Clin. Psychiatry 56 (1995) 5-13
62. Souza F.G.M., and Goodwin G.M. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br. J. Psychiatry 158 (1991) 666-675
63. Tomasiewicz H.C., Mague S.D., Cohen B.M., and Carlezon W.A. Behavioural effects of short-term administration of lithium and valproic acid in rats. Brain Res. 1093 (2006) 83-94
64. Watanabe S., Ishino H., and Otsuki S. Lithium and affective psychoses. Folia Psychiatr. Neurol. Jpn. 28 (1974) 267-305
65. Watanabe S., Ishino H., and Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch. Gen. Psychiatry 32 (1975) 659-668
66. Weerasinghe G.R., Rapoport S.I., and Bosetti F. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63 (2004) 485-489
67. Wegener G., Bandpey Z., Heiberg I.L., Mork A., and Rosenberg R. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology 166 (2003) 188-194
68. Wegener G., Bandpey Z., Heiberg I.L., Volke V., Trabace L., Rosenberg R., and Harvey B.H. Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain. J. Physiol. Pharmacol. 55 (2004) 575-586
69. Worrall E.P., Moody J.P., Peet M., Dick P., Smith A., Chambers C., Adams M., and Naylor G.J. Controlled studies of the acute antidepressant effects of lithium. Br. J. Psychiatry 135 (1979) 255-262
70. Yildiz F., Erden B.F., Ulak G., Utkan T., and Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl.) 149 (2000) 41-44